Clinical Trial Update: Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating amplitude-modulated radiofrequency electromagnetic fields for metastatic pancreatic cancer, and the study is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Amplitude-modulated radiofrequency electromagnetic fields

Snippet

Sponsor: THERABIONIC INC. | Conditions: Pancreatic Cancer, Metastatic Adenocarcinoma | Phase 2 | Status: RECRUITING